KR101612154B1 - Organic compounds and organic electro luminescence device comprising the same - Google Patents

Organic compounds and organic electro luminescence device comprising the same Download PDF

Info

Publication number
KR101612154B1
KR101612154B1 KR1020120145633A KR20120145633A KR101612154B1 KR 101612154 B1 KR101612154 B1 KR 101612154B1 KR 1020120145633 A KR1020120145633 A KR 1020120145633A KR 20120145633 A KR20120145633 A KR 20120145633A KR 101612154 B1 KR101612154 B1 KR 101612154B1
Authority
KR
South Korea
Prior art keywords
mmol
group
inv
synthesis
organic
Prior art date
Application number
KR1020120145633A
Other languages
Korean (ko)
Other versions
KR20140080682A (en
Inventor
백영미
김성무
김회문
이은정
김태형
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Priority to KR1020120145633A priority Critical patent/KR101612154B1/en
Priority to PCT/KR2013/011532 priority patent/WO2014092483A1/en
Publication of KR20140080682A publication Critical patent/KR20140080682A/en
Application granted granted Critical
Publication of KR101612154B1 publication Critical patent/KR101612154B1/en

Links

Classifications

    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/12Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1051Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

본 발명은 신규 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로서, 인돌계 화합물을 호스트 물질로 사용한 발광층을 유기 전계 발광 소자에 도입함으로써 발광효율, 구동 전압 및 수명 등의 특성이 향상된 유기 전계 발광 소자를 제공할 수 있다.The present invention relates to a novel organic compound and an organic electroluminescent device including the organic electroluminescent device. The present invention relates to a novel organic compound and an organic electroluminescent device including the organic electroluminescent device with improved characteristics such as luminous efficiency, driving voltage, Device can be provided.

Description

유기 화합물 및 이를 포함하는 유기 전계 발광 소자{ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE COMPRISING THE SAME}TECHNICAL FIELD [0001] The present invention relates to an organic compound and an organic electroluminescent device including the organic compound.

본 발명은 유기 전계 발광 소자의 재료로 사용될 수 있는 신규 유기 화합물 및 이를 포함하여 소자의 발광효율, 구동전압, 수명 등이 향상되는 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic compound that can be used as a material of an organic electroluminescent device, and an organic electroluminescent device including the same and having improved luminous efficiency, driving voltage, and life span of the device.

1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 하여, 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구가 이어져 오다가, 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후, 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. A study on organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices') led to blue electroluminescence using anthracene single crystals in 1965, starting from the observation of organic thin film emission of Bernanose in the 1950s In 1987, a layered organic EL device was proposed by Tang divided into a hole layer and a functional layer of a light emitting layer. Thereafter, in order to make a high efficiency and high number of organic EL devices, each organic EL device has been developed in a manner of introducing each characteristic organic material layer in the device, leading to the development of specialized materials used therefor.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때, 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic layer in the anode, and electrons are injected into the organic layer in the cathode. When the injected holes and electrons meet, an exciton is formed. When the exciton falls to the ground state, light is emitted. At this time, the material used as the organic material layer can be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, an electron injecting material and the like depending on its function.

발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다. The luminescent material can be classified into blue, green and red luminescent materials according to luminescent colors and yellow and orange luminescent materials necessary for realizing better natural colors. Further, in order to increase the color purity and to increase the luminous efficiency through energy transfer, a host / dopant system can be used as a luminescent material.

도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때, 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있기 때문에, 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대한 연구가 많이 진행되고 있다. The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. At this time, since the phosphorescent material can theoretically improve the luminous efficiency up to 4 times as compared with the fluorescent material, researches on phosphorescent host materials as well as phosphorescent dopants have been conducted.

현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광 재료로는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히, 발광 재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료들은 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색(blue), 녹색(green), 적색(red) 도판트 재료로 사용되고 있으며, 현재까지는 CBP가 인광 호스트 재료로 높은 특성을 나타내고 있다.Up to now, hole injecting layer, hole transporting layer. NPB, BCP, and Alq 3 are widely known as the hole blocking layer and the electron transporting layer, and anthracene derivatives as a luminescent material have been reported as fluorescent dopant / host material. In particular, the phosphor has a great advantage in improving the efficiency aspects of the light-emitting material materials Firpic, Ir (ppy) 3, (acac) Ir (btp) 2 Ir metal complex compound is blue (blue), which includes the same as the green ( green and red dopant materials, and CBP is a phosphorescent host material.

그러나, 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮아 열적 안정성이 매우 좋지 않기 때문에, OLED 소자에서의 수명 측면에서 만족할 만한 수준이 되지 못하는 실정이다. 따라서, 더욱 성능이 뛰어난 재료의 개발이 요구되고 있다.However, existing materials have an advantage in terms of luminescence properties, but their thermal stability is not very good due to their low glass transition temperature, so that they are not satisfactory in terms of lifetime in OLED devices. Therefore, development of materials with higher performance is required.

본 발명은 높은 유리 전이온도로 인해 열적 안정성이 우수하면서, 정공과 전자의 결합력을 향상시킬 수 있는 신규 유기 화합물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a novel organic compound capable of improving the bonding force between holes and electrons while having excellent thermal stability due to a high glass transition temperature.

또, 본 발명은 상기 신규 유기 화합물을 포함하여 구동전압, 발광효율 등이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.It is another object of the present invention to provide an organic electroluminescent device including the novel organic compound and having improved driving voltage, luminous efficiency, and the like.

본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by the following formula (1): < EMI ID =

Figure 112012103902192-pat00001
Figure 112012103902192-pat00001

상기 화학식 1에서,In Formula 1,

R2과 R3, R3과 R4 또는 R4와 R5 중 하나는 하기 화학식 2와 결합하여 축합 고리를 형성하고,R 2 and R 3 , R 3 and R 4 or one of R 4 and R 5 is bonded to the following formula (2) to form a condensed ring,

Figure 112012103902192-pat00002
Figure 112012103902192-pat00002

상기 화학식 2에서 점선은 화학식 1의 화합물과 축합이 이루어지는 부위이며,In the formula (2), the dotted line represents a site where condensation is performed with the compound of the formula (1)

X1 및 X2는 서로 동일하거나 또는 상이하며, 각각 독립적으로 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로부터 선택되고, X1 및 X2 중에서 적어도 하나는 N(Ar1)이며, X 1 and X 2 are the same or different and are each independently selected from O, S, Se, N ( Ar 1), C (Ar 2) (Ar 3) and Si (Ar 4) is selected from (Ar 5) , At least one of X 1 and X 2 is N (Ar 1 )

R1 내지 R9 및 Ra는 서로 동일하거나 또는 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며,R 1 to R 9 and Ra are the same or different and each independently represents hydrogen, deuterium, halogen, cyano, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 A C 6 to C 40 aryl group, a heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 40 aryl An amino group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, is selected from the group consisting of a arylsilyl of C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 of which form a condensed ring by combining tile adjacent In addition,

n은 0 내지 4의 정수이고,n is an integer from 0 to 4,

Ar1 내지 Ar5는 서로 동일하거나 또는 상이하며, 각각 독립적으로 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고,Ar 1 to Ar 5 are the same or different and each independently represents a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group , A heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 40 arylamine group, a C 3 to C 40 cycloalkyl group , A heterocycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 arylboron group, a C 6 to C 40 arylphosphine is selected from the pingi, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 of the group consisting of aryl silyl,

상기 R1 내지 R9, Ra 및 Ar1 내지 Ar5에서, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되는 1종 이상으로 치환될 수 있다. 이때, 치환기가 복수개일 경우, 복수개의 치환기는 서로 동일하거나 또는 상이할 수 있다.In the above R 1 to R 9, Ra and Ar 1 to Ar 5 , a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group , A heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 40 arylamine group, a C 3 to C 40 cycloalkyl group , A heterocycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 arylboron group, a C 6 to C 40 arylphosphine The pinning group, C 6 -C 40 arylphosphine oxide group and C 6 -C 40 arylsilyl group are each independently selected from the group consisting of deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, an aryloxy group of nuclear atoms aryl of from 5 to 40 heteroaryl group, C 6 ~ C 40, alkyloxy group of C 1 ~ C 40 of, C 6 ~ C 40 aryl amine group, C 3 ~ C 40 cycloalkyl group, a 3 to 40 nuclear atoms of a heterocycloalkyl group, C 1 ~ C 40 alkyl silyl group, a alkyl boronic of C 1 ~ C 40, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ aryl phosphine oxide of the C 40 group And an arylsilyl group having from 6 to 40 carbon atoms. Here, when a plurality of substituents are present, a plurality of substituents may be the same or different.

또한, 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중에서 적어도 하나는 상기 화학식 1의 화합물을 포함하는 것이 특징인 유기 전계 발광 소자를 제공한다.Also, the present invention is an organic electroluminescent device comprising a cathode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the one or more organic layers includes a compound of the above formula And an organic electroluminescent device.

여기서, 상기 1층 이상의 유기물층 중 적어도 하나는 정공 주입층, 정공 수송층, 전자수송층, 전자주입층 및 발광층으로 구성된 군으로부터 선택될 수 있으며, 발광층인 것이 바람직하다. 이때, 상기 화학식 1로 표시되는 화합물은 청색, 녹색 또는 적색의 인광 호스트 재료이다.
At least one of the one or more organic layers may be selected from the group consisting of a hole injection layer, a hole transport layer, an electron transport layer, an electron injection layer, and a light emitting layer, and is preferably a light emitting layer. At this time, the compound represented by Formula 1 is a blue, green or red phosphorescent host material.

본 발명의 화학식 1 로 표시되는 화합물은 열적 안정성 및 인광 특성이 우수하기 때문에, 유기 전계 발광 소자의 유기물층의 재료로 사용될 수 있다. 특히, 본 발명의 화학식 1로 표시되는 화합물을 인광 호스트 재료로 사용할 경우, 종래 호스트 재료에 비해 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능 및 수명이 크게 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다.
The compound represented by the general formula (1) of the present invention is excellent in thermal stability and phosphorescence properties and can be used as a material for an organic material layer of an organic electroluminescent device. In particular, when the compound represented by Formula 1 of the present invention is used as a phosphorescent host material, it is possible to produce an organic electroluminescent device having excellent light emitting performance, low driving voltage, high efficiency, and long life time as compared with conventional host materials, And a full color display panel in which the lifetime is greatly improved can also be manufactured.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

<신규 화합물><Novel compound>

본 발명에 따른 신규 화합물은 이미다조인돌 모이어티(imidazoindole moiety)의 말단에 인돌(indole) 모이어티가 융합되어 기본 골격을 이루며, 이러한 기본 골격에 다양한 치환체가 결합된 구조로서, 상기 화학식 1로 표시되는 것을 특징으로 한다.The novel compound according to the present invention has a structure in which an indole moiety is fused to the terminal of an imidazoindole moiety to form a basic skeleton and various substituents are bonded to the basic skeleton. Is displayed.

상기 화학식 1로 표시되는 화합물은 이미다조인돌 모이어티(imidazoindole moiety)의 말단에 결합된 인돌(indole) 모이어티로 인해 넓은 밴드갭을 가질 뿐만 아니라, 다양한 방향족 환 치환체로 인해 분자 전체가 바이폴라(bipolar) 특성을 가지면서, 정공과 전자의 결합력을 높일 수 있다. 따라서 유기 EL 소자의 인광특성을 개선함과 동시에 정공 주입 능력, 수송 능력 또는 발광효율도 개선할 수 있다. The compound represented by Formula 1 has a broad band gap due to an indole moiety bonded to the terminal of an imidazoindole moiety and also has a large number of molecules due to various aromatic ring substituents. bipolar) characteristics, and the bonding strength between holes and electrons can be increased. Therefore, it is possible to improve the phosphorescence characteristic of the organic EL device and improve the hole injecting ability, transporting ability, or light emitting efficiency.

또한, 인돌(indole) 모이어티에 도입된 다양한 방향족 환(aromatic ring) 치환체로 인해 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도가 향상될 수 있고, 이로 인해 종래 CBP(4,4-dicarbazolybiphenyl)보다 높은 열적 안정성을 가질 수 있다. Further, since the aromatic ring substituent introduced into the indole moiety significantly increases the molecular weight of the compound, the glass transition temperature can be improved, and thus, the conventional CBP (4,4-dicarbazolylbiphenyl) It can have higher thermal stability.

아울러, 인돌로인돌 모이어티(indoloindole moiety)의 말단에 결합된 인돌(indole) 모이어티가 융합됨으로써, 화합물의 열적 안정성을 향상시키며 유기물층의 결정화 억제에도 효과적이다. 따라서, 본 발명에 따른 화학식 1의 화합물을 포함하는 유기 EL 소자는 내구성 및 수명 특성이 크게 향상될 수 있다.In addition, the indole moiety bonded to the end of the indole indole moiety is fused with the indole moiety to improve the thermal stability of the compound and to inhibit the crystallization of the organic layer. Therefore, the organic EL device including the compound of Formula 1 according to the present invention can greatly improve durability and lifetime characteristics.

구체적으로, 본 발명의 화학식 1로 표시되는 화합물을 유기 EL 소자의 정공 주입/수송층의 재료로, 청색, 녹색 및/또는 적색의 인광 호스트 재료로 채택할 경우, 종래 CBP 대비 효율 및 수명 면에서 월등히 우수한 효과를 발휘할 수 있다. 따라서, 본 발명의 화학식 1로 표시되는 화합물은 유기 EL 소자의 성능 개선 및 수명 향상에 크게 기여할 수 있으며, 이러한 유기 EL 소자 수명 향상은 풀 칼라 유기 발광 패널에서의 성능 극대화를 가져올 수 있다.Specifically, when the compound represented by the formula (1) of the present invention is used as a blue, green and / or red phosphorescent host material as a material for a positive hole injection / transport layer of an organic EL device, the efficiency and life Excellent effect can be exhibited. Therefore, the compound represented by the general formula (1) of the present invention can greatly contribute to improvement of the performance and lifetime of the organic EL device, and the lifetime of the organic EL device can be maximized in the full color organic light emitting panel.

상기 화학식 2와 결합하여 축합고리가 형성된 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 3 내지 화학식 8 중 어느 하나로 표시되는 화합물로 보다 구체화될 수 있다. 이러한 화학식 3 내지 화학식 8로 표시되는 화합물은 유기 EL 소자의 특성을 고려할 때 바람직하다. The compound represented by the formula (1) of the present invention in which a condensed ring is formed in combination with the formula (2) may be further represented by a compound represented by any one of the following formulas (3) to (8). The compounds represented by the formulas (3) to (8) are preferable in consideration of the characteristics of the organic EL device.

Figure 112012103902192-pat00003
Figure 112012103902192-pat00003

Figure 112012103902192-pat00004
Figure 112012103902192-pat00004

Figure 112012103902192-pat00005
Figure 112012103902192-pat00005

Figure 112012103902192-pat00006
Figure 112012103902192-pat00006

Figure 112012103902192-pat00007
Figure 112012103902192-pat00007

Figure 112012103902192-pat00008
Figure 112012103902192-pat00008

상기 화학식 3 내지 8에서, In the above Formulas 3 to 8,

X1, X2, R1 내지 R9, Ra, Ar1 내지 Ar5 및 n은 상기에서 정의된 바와 같다.X 1 , X 2, R 1 to R 9 , Ra, Ar 1 to Ar 5 and n are as defined above.

보다 구체적으로, 상기 X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로부터 선택되고, X1 및 X2 중에서 적어도 하나는 N(Ar1)이다. 바람직하게는 X1 및 X2 모두 N(Ar1)이다. 이때 X1 및 X2가 N(Ar1)인 경우, 각각의 Ar1은 동일하거나 또는 상이하다.More specifically, X 1 and X 2 are each independently selected from O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ) 1 and X &lt; 2 &gt; is N (Ar &lt; 1 &gt;). Preferably, both X 1 and X 2 are N (Ar 1 ). When X 1 and X 2 are N (Ar 1 ), each Ar 1 is the same or different.

또한, Ar1 내지 Ar5 는 서로 동일하거나 또는 상이하며, 각각 독립적으로 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된다.Ar 1 to Ar 5 are the same or different and each independently represents a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 40 An aryl group, a heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 40 arylamine group, a C 3 to C 40 A cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 arylboron group, a C 6 to C 40 an aryl phosphine group, and is selected from the group consisting of C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl group in the silyl.

이때 유기 EL 소자의 특성을 더 고려할 때, 상기 Ar1 내지 Ar5는 서로 동일하거나 또는 상이하며, 각각 독립적으로 치환되거나 비치환된 C6~C40의 아릴기, 또는 치환되거나 비치환된 핵원자수 5 내지 40의 헤테로아릴기인 것이 바람직하다. When considering the characteristics of the organic EL device, the above Ar 1 to Ar 5 may be the same or different and each independently represents a substituted or unsubstituted C 6 to C 40 aryl group or a substituted or unsubstituted nuclear atom More preferably 5 to 40 heteroaryl groups.

아울러, 화학식 2와 축합고리를 비형성하는 치환기, 일례로, R2와 R3, R3과 R4, 및/또는 R4와 R5 중 적어도 하나를 제외하는 R1 내지 R9, Ra는 서로 동일하거나 또는 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있다. Further, R 1 to R 9 , Ra in which at least one of R 2 and R 3 , R 3 and R 4 , and / or R 4 and R 5 are excluded is a substituent which does not form a condensed ring with the formula (2) be the same or different and are each independently hydrogen, deuterium, halogen, cyano, C 1 ~ alkynyl group of C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 of, C 6 ~ C 40 the aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, C 6 ~ C 40 aryloxy group, alkyloxy group of C 1 ~ C 40 of, C 6 ~ arylamine group of C 40, C 3 ~ C 40 A cycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 arylboron group, a C 6 to C 40 aralkyl group, An arylphosphine group of C 6 to C 40 , an arylphosphine oxide group of C 6 to C 40 , and an arylsilyl group of C 6 to C 40 , which may be bonded to adjacent groups to form a condensed ring.

본 발명에서, R1 내지 R9, Ra는 각각 독립적으로 수소, 중수소(D), 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 및 치환 또는 비치환된 C6~C40의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하다. In the present invention, R 1 to R 9 and Ra each independently represent hydrogen, deuterium (D), a substituted or unsubstituted C 6 to C 40 aryl group, a substituted or unsubstituted heteroaryl having 5 to 40 nucleus And a substituted or unsubstituted C 6 to C 40 arylamine group.

여기서, 상기 R1 내지 R9, Ra 및 Ar1 내지 Ar5에서, 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기, 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되는 1종 이상으로 치환될 수 있다. 이때 치환기가 복수개일 경우, 복수개의 치환기는 서로 동일하거나 또는 상이할 수 있다.In the above R 1 to R 9, Ra and Ar 1 to Ar 5 , an alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, cycloalkyl group, heterocyclo An alkyl group, an alkylsilyl group, an alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylsilyl group are each independently selected from the group consisting of deuterium, halogen, cyano group, C 1 to C 40 alkyl group, C 2 to C 40 A C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group, a heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyl oxy group, C 6 ~ C 40 aryl amine group, a C 3 ~ C 40 cycloalkyl group, the nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkyl silyl group, an alkyl of C 1 ~ C 40 boron group, C 6 ~ C 40 aryl group of boron, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl group selected from the group consisting of a silyl It may be substituted with at least one member. When there are a plurality of substituents, the plurality of substituents may be the same as or different from each other.

본 발명에 따른 화학식 1의 화합물에서, R1 내지 R11 및 Ra, Ar1 내지 Ar5는 각각 독립적으로, 수소 또는 하기 S1 내지 S204로 표시되는 치환체 군에서 선택되는 것이 바람직하나, 이에 한정되지는 않는다. In the compound of formula (I) according to the present invention, R 1 to R 11 and Ra and Ar 1 to Ar 5 are each independently preferably selected from the group consisting of hydrogen or the substituents represented by the following S1 to S204, Do not.

Figure 112012103902192-pat00009
Figure 112012103902192-pat00009

Figure 112012103902192-pat00010

Figure 112012103902192-pat00010

Figure 112012103902192-pat00011
Figure 112012103902192-pat00011

보다 바람직하게는 R1 내지 R11 및 Ra, Ar1 내지 Ar5 는 각각 독립적으로 수소 또는 하기 치환체 군에서 선택될 수 있다.More preferably, R 1 to R 11 and Ra and Ar 1 to Ar 5 each independently may be selected from hydrogen or the following substituent group.

Figure 112012103902192-pat00012
Figure 112012103902192-pat00012

이상에서 설명한 본 발명의 화합물은 하기 예시된 구조들로 보다 구체화될 수 있다. 그러나 본 발명의 화학식 1로 표시되는 화합물이 하기 예시된 것들에 의해 한정되는 것은 아니다.The compounds of the present invention described above can be further exemplified by the following exemplified structures. However, the compounds represented by formula (1) of the present invention are not limited by the following examples.

Figure 112012103902192-pat00013
Figure 112012103902192-pat00013

Figure 112012103902192-pat00014
Figure 112012103902192-pat00014

Figure 112012103902192-pat00015
Figure 112012103902192-pat00015

Figure 112012103902192-pat00016
Figure 112012103902192-pat00016

Figure 112012103902192-pat00017
Figure 112012103902192-pat00017

Figure 112012103902192-pat00018
Figure 112012103902192-pat00018

Figure 112012103902192-pat00019

Figure 112012103902192-pat00019

한편, 본 발명에서의 "알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있다.In the present invention, "alkyl" is a monovalent substituent derived from a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms, and examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, , Hexyl, and the like.

본 발명에서의 "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있다.The "alkenyl" in the present invention is a monovalent substituent derived from a straight-chain or branched-chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples thereof include vinyl, allyl allyl, isopropenyl, 2-butenyl, and the like.

본 발명에서의 "알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있다."Alkynyl" in the present invention is a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Examples thereof include ethynyl, 2-propynyl, and the like.

본 발명에서의 "아릴"은 단독 고리 또는 2이상의 고리가 조합된 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있다.In the present invention, "aryl" means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. Also, a form in which two or more rings are pendant or condensed with each other may be included. Examples of such aryl include phenyl, naphthyl, phenanthryl, anthryl and the like.

본 발명에서의 "헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석한다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리, 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리, 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있다."Heteroaryl" in the present invention means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. Wherein at least one of the carbons, preferably one to three carbons, is replaced by a heteroatom such as N, O, S or Se. In addition, it is understood that a form in which two or more rings are pendant or condensed with each other may be included, and further includes a condensed form with an aryl group. Examples of such heteroaryls include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolizinyl, indolyl indolyl), purinyl, quinolyl, benzothiazole, carbazolyl, 2-furanyl, N-imidazolyl, 2- isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like.

본 발명에서의 "아릴옥시"는 RO-로 표시되는 1가의 치환기로 상기 R은 탄소수 5 내지 60의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있다.In the present invention, "aryloxy" means a monovalent substituent represented by RO-, and R represents aryl having 5 to 60 carbon atoms. Examples of such aryloxy include phenyloxy, naphthyloxy, diphenyloxy and the like.

본 발명에서의 "알킬옥시"는 R'O-로 표시되는 1가의 치환기로 상기 R'는 1 내지 40개의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 이러한 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있다.The term "alkyloxy" in the present invention means a monovalent substituent group represented by R'O-, wherein R 'represents 1 to 40 alkyl, and may have a linear, branched or cyclic structure . Examples of such alkyloxy include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.

본 발명에서의 "아릴아민"은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다."Arylamine" in the present invention means an amine substituted with aryl having 6 to 60 carbon atoms.

본 발명에서의 "시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있다."Cycloalkyl" in the present invention means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyls include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.

본 발명에서의 "헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있다."Heterocycloalkyl" in the present invention means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, wherein at least one carbon, preferably 1 to 3 carbons, of the ring is replaced by N, O, S or Se. &Lt; / RTI &gt; Examples of such heterocycloalkyl include morpholine, piperazine and the like.

본 발명에서의 "알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴을 의미한다."Alkylsilyl" in the present invention means a silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" means silyl substituted with aryl having 5 to 40 carbon atoms.

본 발명에서의 "축합고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, the term "condensed rings" means condensed aliphatic rings, condensed aromatic rings, condensed heteroaliphatic rings, condensed heteroaromatic rings, or a combination thereof.

본 발명의 화학식 1의 화합물은 하기 합성예를 참조하여 다양하게 합성할 수 있다. 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다.
The compounds of formula (1) of the present invention can be synthesized in various ways with reference to the following Synthesis Examples. Detailed synthesis of the compound of the present invention will be described in detail in Synthesis Examples to be described later.

<유기 전계 발광 소자>&Lt; Organic electroluminescent device &

한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자에 관한 것이다. According to another aspect of the present invention, there is provided an organic electroluminescent device comprising the compound represented by Formula 1 according to the present invention.

구체적으로, 본 발명의 유기 전계 발광 소자는 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물, 바람직하게는 화학식 3 내지 화학식 8로 표시되는 화합물을 포함한다. 이때, 상기 화학식 1의 화합물은 단독으로 사용되거나, 또는 2 이상이 혼합되어 사용될 수 있다.Specifically, the organic electroluminescent device of the present invention includes an anode, a cathode, and at least one organic layer sandwiched between the anode and the cathode, A compound represented by the formula (1), preferably a compound represented by the formula (3) to (8). At this time, the compound of formula (1) may be used alone or in combination of two or more.

상기 1층 이상의 유기물층은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 이때, 상기 화학식 1의 화합물을 포함하는 유기물층은 발광층인 것이 바람직하다.The one or more organic layers may be at least one of a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer, and at least one of the organic layers may include a compound represented by Formula 1. [ At this time, it is preferable that the organic material layer including the compound of Formula 1 is a light emitting layer.

구체적으로, 본 발명의 유기 전계 발광 소자의 발광층은 호스트 재료를 포함할 수 있는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 이와 같이, 상기 화학식 1의 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트 재료로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등이 향상될 수 있다.Specifically, the light emitting layer of the organic electroluminescent device of the present invention may include a host material, which may include the compound of Formula 1 as a host material. When the compound of Formula 1 is included in the light emitting layer material of the organic electroluminescent device, preferably blue, green, and red phosphorescent host materials, the bonding strength between holes and electrons in the light emitting layer increases, Efficiency (luminous efficiency and power efficiency), lifetime, luminance, driving voltage, and the like can be improved.

본 발명에 따른 유기 전계 발광 소자의 구조는 특별히 한정되지 않으며, 예컨대 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 발광층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 구체적으로, 본 발명의 화학식 1로 표시되는 화합물은 발광층의 인광 호스트 재료로 이용될 수 있다. 한편, 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다. The structure of the organic electroluminescent device according to the present invention is not particularly limited and may be a structure in which a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode are sequentially laminated. At least one of the hole injecting layer, the hole transporting layer, the light emitting layer, the electron transporting layer, and the electron injecting layer may include a compound represented by Formula 1, and preferably, the emitting layer includes a compound represented by Formula 1 . Specifically, the compound represented by the general formula (1) of the present invention can be used as a phosphorescent host material in the light emitting layer. On the other hand, an electron injection layer may be further stacked on the electron transport layer.

또한, 본 발명에 따른 유기 전계 발광 소자의 구조는 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층될 뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.In addition, the structure of the organic electroluminescent device according to the present invention may be a structure in which an anode, one or more organic layers and an anode are sequentially laminated, and an insulating layer or an adhesive layer is inserted into the interface between the electrode and the organic layer.

본 발명에 따른 유기 전계 발광 소자는 상기 유기물층 중 1층 이상(예컨대, 발광층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당 업계에 알려져 있는 재료 및 방법을 이용하여 다른 유기물층 및 전극을 형성하여 제조할 수 있다.The organic electroluminescent device according to the present invention may be formed by using materials and methods known in the art, except that at least one of the organic material layers (for example, the light emitting layer) An organic material layer and an electrode.

상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에 한정되지 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.

본 발명에서 사용 가능한 기판으로는 특별히 한정되지 않으며, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등이 사용될 수 있다.The substrate usable in the present invention is not particularly limited, and a silicon wafer, quartz, a glass plate, a metal plate, a plastic film and a sheet can be used.

또, 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 있는데, 이에 한정되지 않는다.Examples of the positive electrode material include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.

또, 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있는데, 이에 한정되지 않는다.The negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or an alloy thereof; And multi-layer structure materials such as LiF / Al or LiO 2 / Al, but are not limited thereto.

또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 알려진 통상의 물질이 사용될 수 있다.The hole injecting layer, the hole transporting layer, the electron injecting layer and the electron transporting layer are not particularly limited, and conventional materials known in the art can be used.

이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited by the following examples.

[준비예 1] IIC-1의 합성[Preparation Example 1] Synthesis of IIC-1

<단계 1> 5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole의 합성<Step 1> Synthesis of 5- (3-bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole

Figure 112012103902192-pat00020
Figure 112012103902192-pat00020

질소 기류 하에서 11.85 g (39.6 mmol)의 5-bromo-1,2-diphenyl-1H-imidazole, 11.68 g (47.5 mmol)의 3-bromo-2-nitrophenylboronic acid, 4.75 g (118.8 mmol)의 NaOH과 200 ml/100 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 2.29 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 2시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 11.15 g (26.5 mmol, yield: 67 %)을 획득하였다. 11.85 g (39.6 mmol) of 5-bromo-1,2-diphenyl-1H-imidazole and 11.68 g (47.5 mmol) of 3-bromo-2-nitrophenylboronic acid, 4.75 g (118.8 mmol) ml / 100 ml of THF / H 2 O were added and stirred. At 40 ℃ into the Pd (PPh 3) 4 of 2.29 g (5 mol%) was stirred for 2 h at 80 ℃. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 11.15 g (26.5 mmol, yield: 67%) of 5- (3-bromo-2-nitrophenyl) -1,2- diphenyl-1H- imidazole .

1H-NMR : δ 7.43 (m, 2H), 7.55 (m, 6H), 7.64 (s, 1H), 7.86 (m, 3H), 8.24 (d, 2H)
1 H-NMR: δ 7.43 ( m, 2H), 7.55 (m, 6H), 7.64 (s, 1H), 7.86 (m, 3H), 8.24 (d, 2H)

<단계 2> 5-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 2> Synthesis of 5-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00021
Figure 112012103902192-pat00021

질소 기류 하에서 5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 9.12 g (21.7 mmol)과 triphenylphosphine 14.2 g (54.2 mmol), 1,2-dichlorobenzene 100 ml를 넣은 후 12시간 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 추출된 유기층은 MgSO4로 물을 제거하고, 컬럼크로마토그래피를 이용하여 목적 화합물인 5-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.75 g, (14.8 mmol, yield : 68 %)을 획득하였다. 9.12 g (21.7 mmol) of 5- (3-bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole, 14.2 g (54.2 mmol) of triphenylphosphine and 100 ml of 1,2- dichlorobenzene were placed under a nitrogen stream, Lt; / RTI &gt; After completion of the reaction, 1,2-dichlorobenzene was removed and extracted with dichloromethane. The extracted organic layer was washed with MgSO 4 and purified by column chromatography to obtain 5.75 g of the target compound 5-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole, , yield: 68%).

1H-NMR : δ 7.22 (t, 1H), 7.43 (m, 3H), 7.54 (m, 6H), 8.04 (d, 1H), 8.25 (d, 2H), 11.32 (s, 1H)
1 H-NMR:? 7.22 (t, 1 H), 7.43 (m, 3H), 7.54 (m, 6H), 8.04 (d,

<단계 3> 5-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 3> Synthesis of 5-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00022
Figure 112012103902192-pat00022

질소 기류 하에서 5-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.5 g (14.2 mmol), iodobenzene (5.79 g, 28.4 mmol), Cu powder (0.1 g, 1.42 mmol), K2CO3 (1.96 g, 14.2 mmol), Na2SO4 (2.02 g, 14.2 mmol), nitrobenzene (100 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 5.5 g (14.2 mmol) of indole 5-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole, iodobenzene (5.79 g, 28.4 mmol) and Cu powder (0.1 g, ), K 2 CO 3 (1.96 g, 14.2 mmol), Na 2 SO 4 (2.02 g, 14.2 mmol) and nitrobenzene (100 ml) were mixed and stirred at 210 ° C for 12 hours.

반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피로 정제하여 5-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.88 g (10.5 mmol, yield: 74 %)을 얻었다. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removal of the solvent from the organic layer from which water had been removed, the residue was purified by column chromatography to obtain 4.88 g (10.5 mmol, yield: 74%) of 5-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [ %).

1H-NMR : δ 7.21 (m, 2H), 7.44 (m, 3H), 7.54 (m, 10H), 8.25 (d, 2H), 8.63 (d, 1H)
1 H-NMR: δ 7.21 ( m, 2H), 7.44 (m, 3H), 7.54 (m, 10H), 8.25 (d, 2H), 8.63 (d, 1H)

<단계 4> 5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 4> Synthesis of 5- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00023
Figure 112012103902192-pat00023

질소 기류 하에서 4.88 g (10.5 mmol)의 5-bromo-1,2-diphenyl-1H-imidazole, 2.1 g (12.6 mmol)의 2-nitrophenylboronic acid, 1.26 g (31.5 mmol)의 NaOH과 100 ml/50 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 0.61 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 2시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol, yield: 87 %)을 획득하였다. 2-nitrophenylboronic acid and 1.26 g (31.5 mmol) of NaOH and 2.1 g (12.6 mmol) of 5-bromo-1,2-diphenyl-1H-imidazole and 100 ml / 50 ml Of THF / H 2 O were added and stirred. At 40 ℃ 0.61 g (5 mol% ) into the Pd (PPh 3) 4 was stirred for 2 h at 80 ℃. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 4.63 g (9.14 mmol) of the desired compound 5- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5- mmol, yield: 87%).

1H-NMR : δ 7.31 (t, 1H), 7.44 (m, 3H), 7.56 (m, 10H), 7.67 (t, 1H), 8.02 (m, 3H), 8.28 (m, 3H), 8.68 (d, 1H)
1 H-NMR: 8 7.31 (t, 1 H), 7.44 (m, 3H), 7.56 (m, 10H), 7.67 d, 1 H)

<단계 5> IIC-1의 합성<Step 5> Synthesis of IIC-1

Figure 112012103902192-pat00024
Figure 112012103902192-pat00024

5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 대신 5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 목적화합물 IIC-1 3.30 g (6.95 mmol, yield : 76 %)을 얻었다. Substituting 5- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] pyridine instead of 5- (3-bromo- 3.30 g (6.95 mmol, yield: 76%) of the desired compound IIC-1 was obtained by carrying out the same procedure as <Step 2> of Preparation Example 1, except that indole 4.63 g (9.14 mmol)

1H-NMR : δ 7.31 (t, 1H), 7.45 (m, 3H), 7.54 (m, 12H), 7.64 (d, 1H), 8.12 (d, 1H), 8.28 (d, 2H), 8.48 (d, 1H), 11.21 (s, 1H)
1 H-NMR: δ 7.31 ( t, 1H), 7.45 (m, 3H), 7.54 (m, 12H), 7.64 (d, 1H), 8.12 (d, 1H), 8.28 (d, 2H), 8.48 ( d, 1 H), 11.21 (s, 1 H)

[준비예2] IIC-2 와 IIC-3의 합성[Preparation Example 2] Synthesis of IIC-2 and IIC-3

<단계 1> 5-(4-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole의 합성<Step 1> Synthesis of 5- (4-bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole

Figure 112012103902192-pat00025
Figure 112012103902192-pat00025

3-bromo-2-nitrophenylboronic acid 대신 4-bromo-2-nitrophenylboronic acid 11.68 g (47.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 5-(4-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 11.5 g (27.3 mmol, yield: 69 %)을 얻었다.The procedure of Step 1 of Preparation Example 1 was repeated except that 11.68 g (47.5 mmol) of 4-bromo-2-nitrophenylboronic acid was used in place of 3-bromo-2-nitrophenylboronic acid to obtain 5- (4 -bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole (27.5 mmol, yield: 69%).

1H-NMR : δ 7.42 (m, 2H), 7.55 (m, 6H), 7.65 (s, 1H), 7.99 (m, 2H), 8.28 (d, 2H), 8.62 (s, 1H)
1 H-NMR: δ 7.42 ( m, 2H), 7.55 (m, 6H), 7.65 (s, 1H), 7.99 (m, 2H), 8.28 (d, 2H), 8.62 (s, 1H)

<단계 2> 6-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 2> Synthesis of 6-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00026
Figure 112012103902192-pat00026

5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 대신 5-(4-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 9.12 g (21.7 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 6-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.90 g (15.2 mmol, yield: 70 %)을 얻었다.9.12 g (21.7 mmol) of 5- (4-bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole was used instead of 5- (3-bromo-2-nitrophenyl) The procedure of Step 2 of Preparation Example 1 was repeated to obtain 5.90 g (15.2 mmol) of 6-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5- , yield: 70%).

1H-NMR : δ 7.40 (m, 3H), 7.55 (m, 7H), 7.99 (d, 1H), 8.29 (d, 2H), 11.33 (s, 1H)
1 H-NMR:? 7.40 (m, 3H), 7.55 (m, 7H), 7.99

<단계 3> 6-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 3> Synthesis of 6-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00027
Figure 112012103902192-pat00027

5-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 6-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.5 g (14.2 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 5.14 g (11.1 mmol, yield: 78%)을 얻었다.5.5 g of 6-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole was used instead of 5-bromo-1,2-diphenyl-1,4-dihydroimidazo [ 4-triphenyl-1,4-dihydroimidazo [4,5-b] pyridine was prepared by following the procedure of Step 3 of Preparation Example 1, 5.14 g (11.1 mmol, yield: 78%) of indole were obtained.

1H-NMR : δ 7.19 (d, 1H), 7.45 (m, 3H), 7.58 (m, 10H), 8.27 (m, 3H), 8.73 (s, 1H)
1 H-NMR:? 7.19 (d, 1 H), 7.45 (m, 3H), 7.58 (m,

<단계 4> 6-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 4> Synthesis of 6- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00028
Figure 112012103902192-pat00028

5-bromo-1,2-diphenyl-1H-imidazole 대신 6-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.88 g (10.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol, yield: 87 %)을 얻었다.Except that 4.88 g (10.5 mmol) of 6-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole was used instead of 5-bromo-1,2-diphenyl- 4-dihydroimidazo [4,5-b] indole was obtained by carrying out the same procedure as in the step 4 of Preparation Example 1 to obtain 4.63 g of (6- (2-nitrophenyl) -1,2,4-triphenyl- 9.14 mmol, yield: 87%).

1H-NMR : δ 7.42 (m, 3H), 7.57 (m, 10H), 7.63 (m, 2H), 8.02 (m. 3H), 8.27 (d, 2H), 8.49 (s, 1H)
1 H-NMR: δ 7.42 ( m, 3H), 7.57 (m, 10H), 7.63 (m, 2H), 8.02 (. M 3H), 8.27 (d, 2H), 8.49 (s, 1H)

<단계 5> IIC-2 와 IIC-3의 합성<Step 5> Synthesis of IIC-2 and IIC-3

Figure 112012103902192-pat00029
Figure 112012103902192-pat00029

5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 6-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 5>와 동일한 과정을 수행하여 IIC-2 1.56 g (3.29 mmol, yield: 36 %)와 IIC-3 1.43 g (3.02 mmol, yield: 33 %)을 얻었다.Instead of 6- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5- The procedure of Step 5 of Preparation Example 1 was repeated except that 4.63 g (9.14 mmol) of dihydroimidazo [4,5-b] indole was used, yielding 1.56 g (3.29 mmol, yield: 36 %) And 1.43 g (3.02 mmol, yield: 33%) of IIC-3.

IIC-2의 1H-NMR : δ 7.30 (t, 1H), 7.43 (m, 3H), 7.55 (m, 11H), 7.63 (d, 1H), 7.89 (d, 1H), 8.12 (d, 1H), 8.27 (d, 2H), 8.43 (d, 1H), 10.22 (s, 1H)Of IIC-2 1 H-NMR: δ 7.30 (t, 1H), 7.43 (m, 3H), 7.55 (m, 11H), 7.63 (d, 1H), 7.89 (d, 1H), 8.12 (d, 1H ), 8.27 (d, 2H), 8.43 (d, IH), 10.22 (s, IH)

IIC-3의 1H-NMR : δ 7.30 (t, 1H), 7.44 (m, 4H), 7.54 (m, 12H), 7.63 (d, 1H), 8.12 (d, 1H), 8.28 (d, 2H), 10.21 (s, 1H)
1 of the IIC-3 H-NMR: δ 7.30 (t, 1H), 7.44 (m, 4H), 7.54 (m, 12H), 7.63 (d, 1H), 8.12 (d, 1H), 8.28 (d, 2H ), 10.21 (s, 1 H)

[준비예3] IIC-4 와 IIC-5의 합성[Preparation Example 3] Synthesis of IIC-4 and IIC-5

<단계 1> 5-(5-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole의 합성<Step 1> Synthesis of 5- (5-bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole

Figure 112012103902192-pat00030
Figure 112012103902192-pat00030

3-bromo-2-nitrophenylboronic acid 대신 5-bromo-2-nitrophenylboronic acid 11.68 g (47.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 11.3 g (26.9 mmol, yield: 68 %)을 얻었다.The procedure of Step 1 of Preparation Example 1 was repeated except that 11.68 g (47.5 mmol) of 5-bromo-2-nitrophenylboronic acid was used in place of 3-bromo-2-nitrophenylboronic acid to obtain 5- (5 -bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole 11.3 g (26.9 mmol, yield: 68%).

1H-NMR : δ 7.42 (m, 2H), 7.53 (m, 6H), 7.65 (s, 1H), 7.76 (s, 1H), 7.99 (d, 1H), 8.24 (m, 3H)
1 H-NMR: δ 7.42 ( m, 2H), 7.53 (m, 6H), 7.65 (s, 1H), 7.76 (s, 1H), 7.99 (d, 1H), 8.24 (m, 3H)

<단계 2> 7-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 2> Synthesis of 7-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00031
Figure 112012103902192-pat00031

5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 대신 5-(5-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 9.12 g (21.7 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 7-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 6.15 g (15.9 mmol, yield: 73 %)을 얻었다.9.12 g (21.7 mmol) of 5- (5-bromo-2-nitrophenyl) -1,2-diphenyl-1H-imidazole was used instead of 5- (3-bromo-2-nitrophenyl) 6.15 g (15.9 mmol) of 7-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole were obtained by carrying out the same processes as in <Step 2> of Preparation Example 1, , yield: 73%).

1H-NMR : δ 7.42 (m, 3H), 7.55 (m, 7H), 7.99 (s, 1H), 8.28 (d, 2H), 11.33 (s, 1H)
1 H-NMR:? 7.42 (m, 3H), 7.55 (m, 7H), 7.99

<단계 3> 7-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 3> Synthesis of 7-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00032
Figure 112012103902192-pat00032

5-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 7-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.5 g (14.2 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 7-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.94 g (10.7 mmol, yield: 75%)을 얻었다.5.5 g of 7-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole was used instead of 5-bromo-1,2-diphenyl-1,4-dihydroimidazo [ 4-triphenyl-1,4-dihydroimidazo [4,5-b] pyridine was prepared by following the procedure of Step 3 of Preparation Example 1, indole 4.94 g (10.7 mmol, yield: 75%).

1H-NMR : δ 7.25 (d, 1H), 7.44 (m, 3H), 7.54 (m, 10H), 7.79 (d, 2H), 8.27 (d, 2H)
1 H-NMR: δ 7.25 ( d, 1H), 7.44 (m, 3H), 7.54 (m, 10H), 7.79 (d, 2H), 8.27 (d, 2H)

<단계 4> 7-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 4> Synthesis of 7- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00033
Figure 112012103902192-pat00033

5-bromo-1,2-diphenyl-1H-imidazole 대신 7-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.88 g (10.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 7-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol, yield: 87 %)을 얻었다.Except that 4.88 g (10.5 mmol) of 7-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole was used instead of 5-bromo-1,2-diphenyl- 4-dihydroimidazo [4,5-b] indole was obtained by carrying out the same procedure as Step 4 of Preparation Example 1 with the exception of using 4.63 g of (2-nitrophenyl) -1,2,4-triphenyl- 9.14 mmol, yield: 87%).

1H-NMR : δ 7.45 (m, 3H), 7.54 (m, 10H), 7.72 (m, 2H), 7.99 (m, 4H), 8.18 (d, 1H), 8.27 (d, 2H)
1 H-NMR: δ 7.45 ( m, 3H), 7.54 (m, 10H), 7.72 (m, 2H), 7.99 (m, 4H), 8.18 (d, 1H), 8.27 (d, 2H)

<단계 5> IIC-4 와 IIC-5의 합성<Step 5> Synthesis of IIC-4 and IIC-5

Figure 112012103902192-pat00034
Figure 112012103902192-pat00034

5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 7-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 5>와 동일한 과정을 수행하여 IIC-4 1.48 g (3.11 mmol, yield: 34 %)와 IIC-5 1.73 g (3.66 mmol, yield: 40 %)을 얻었다.Instead of 7- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5- The procedure of Step 5 of Preparation Example 1 was repeated except that 4.63 g (9.14 mmol) of dihydroimidazo [4,5-b] indole was used, yielding 1.48 g (3.11 mmol, yield: 34 %) And 1.73 g (3.66 mmol, yield: 40%) of IIC-5.

IIC-4의 1H-NMR : δ 7.30 (t, 1H), 7.43 (m, 4H), 7.53 (m, 12H), 7.63 (d, 1H), 8.12 (d, 1H), 8.28 (d, 2H), 10.21 (s, 1H) 1 H-NMR of IIC-4: 8 7.30 (t, 1H), 7.43 (m, 4H), 7.53 (m, 12H), 7.63 (d, ), 10.21 (s, 1 H)

IIC-5의 1H-NMR : δ 7.29 (t, 1H), 7.44 (m, 3H), 7.55 (m, 11H), 7.63 (d, 1H), 7.96 (m, 2H), 8.12 (d, 1H), 8.27 (d, 2H), 10.22 (s, 1H)
Of IIC-5 1 H-NMR: δ 7.29 (t, 1H), 7.44 (m, 3H), 7.55 (m, 11H), 7.63 (d, 1H), 7.96 (m, 2H), 8.12 (d, 1H ), 8.27 (d, 2H), 10.22 (s, 1 H)

[준비예4] IIC-6의 합성[Preparation Example 4] Synthesis of IIC-6

<단계 1> 5-(2-bromo-6-nitrophenyl)-1,2-diphenyl-1H-imidazole의 합성<Step 1> Synthesis of 5- (2-bromo-6-nitrophenyl) -1,2-diphenyl-1H-imidazole

Figure 112012103902192-pat00035
Figure 112012103902192-pat00035

3-bromo-2-nitrophenylboronic acid 대신 2-bromo-6-nitrophenylboronic acid 11.68 g (47.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 5-(2-bromo-6-nitrophenyl)-1,2-diphenyl-1H-imidazole 11.3 g (26.9 mmol, yield: 68 %)을 얻었다.The same procedure as in <Step 1> of Preparation Example 1 was carried out except that 11.68 g (47.5 mmol) of 2-bromo-6-nitrophenylboronic acid was used in place of 3-bromo-2-nitrophenylboronic acid to obtain 5- (2 -bromo-6-nitrophenyl) -1,2-diphenyl-1H-imidazole 11.3 g (26.9 mmol, yield: 68%).

1H-NMR : δ 7.42 (m, 2H), 7.55 (m ,7H), 7.65 (s, 1H), 7.99 (m, 2H), 8.27 (d, 2H)
1 H-NMR: δ 7.42 ( m, 2H), 7.55 (m, 7H), 7.65 (s, 1H), 7.99 (m, 2H), 8.27 (d, 2H)

<단계 2> 8-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 의 합성<Step 2> Synthesis of 8-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00036
Figure 112012103902192-pat00036

5-(3-bromo-2-nitrophenyl)-1,2-diphenyl-1H-imidazole 대신 5-(2-bromo-6-nitrophenyl)-1,2-diphenyl-1H-imidazole 9.12 g (21.7 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 8-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.90 g (15.2 mmol, yield: 70 %)을 얻었다.9.12 g (21.7 mmol) of 5- (2-bromo-6-nitrophenyl) -1,2-diphenyl-1H-imidazole was used instead of 5- (3-bromo- Bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole was obtained in the same manner as in <Step 2> of Preparation Example 1, , yield: 70%).

1H-NMR : δ 7.27 (t, 1H), 7.33 (d, 1H), 7.42 (m, 2H), 7.56 (m ,7H), 8.27 (d, 2H), 11.32 (s, 1H)
1 H-NMR: δ 7.27 ( t, 1H), 7.33 (d, 1H), 7.42 (m, 2H), 7.56 (m, 7H), 8.27 (d, 2H), 11.32 (s, 1H)

<단계 3> 8-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성 <Step 3> Synthesis of 8-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [ 4,5-b] indole

Figure 112012103902192-pat00037
Figure 112012103902192-pat00037

5-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 8-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 5.5 g (14.2 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 8-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.94 g (10.7 mmol, yield: 75%)을 얻었다.Instead of 5-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] Bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] pyridine was prepared by following the procedure of Step 3 of Preparation Example 1, indole 4.94 g (10.7 mmol, yield: 75%).

1H-NMR : δ 7.17 (d, 1H), 7.23 (t, 1H), 7.44 (m, 3H), 7.54 (m ,10H), 7.88 (d, 1H), 8.27 (d, 2H)
1 H-NMR: δ 7.17 ( d, 1H), 7.23 (t, 1H), 7.44 (m, 3H), 7.54 (m, 10H), 7.88 (d, 1H), 8.27 (d, 2H)

<단계 4> 8-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 4> Synthesis of 8- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00038
Figure 112012103902192-pat00038

5-bromo-1,2-diphenyl-1H-imidazole 대신 8-bromo-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.88 g (10.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 8-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.68 g (9.25 mmol, yield: 88 %)을 얻었다.Except that 4.88 g (10.5 mmol) of 8-bromo-1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole was used instead of 5-bromo-1,2-diphenyl- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5-b] indole in the same manner as in Step 4 of Preparation Example 1 9.25 mmol, yield: 88%).

1H-NMR : δ 7.38 (t, 1H), 7.43 (m, 3H), 7.55 (m ,10H), 7.67 (t, 1H), 7.98 (m, 5H), 8.28 (d, 2H)
1 H-NMR: δ 7.38 ( t, 1H), 7.43 (m, 3H), 7.55 (m, 10H), 7.67 (t, 1H), 7.98 (m, 5H), 8.28 (d, 2H)

<단계 5> IIC-6의 합성<Step 5> Synthesis of IIC-6

Figure 112012103902192-pat00039
Figure 112012103902192-pat00039

5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 8-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 4.63 g (9.14 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 5>와 동일한 과정을 수행하여 IIC-6 2.95 g (6.22 mmol, yield: 68 %)을 얻었다.Instead of 8- (2-nitrophenyl) -1,2,4-triphenyl-1,4-dihydroimidazo [4,5- The procedure of Step 5 of Preparation Example 1 was repeated except that 4.63 g (9.14 mmol) of dihydroimidazo [4,5-b] indole was used to yield 2.95 g (6.22 mmol, yield: 68 %).

1H-NMR : δ 7.28 (t, 1H), 7.43 (m, 3H), 7.56 (m ,11H), 7.63 (m, 1H), 7.94 (d, 1H), 8.12 (d, 1H), 8.28 (d, 2H), 11.21 (s, 1H)
1 H-NMR: δ 7.28 ( t, 1H), 7.43 (m, 3H), 7.56 (m, 11H), 7.63 (m, 1H), 7.94 (d, 1H), 8.12 (d, 1H), 8.28 ( d, 2 H), 11.21 (s, 1 H)

[준비예5] IIC-7 과 IIC-8의 합성[Preparation Example 5] Synthesis of IIC-7 and IIC-8

<단계 1> 7-(2-nitrophenyl)-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성<Step 1> Synthesis of 7- (2-nitrophenyl) -1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole

Figure 112012103902192-pat00040
Figure 112012103902192-pat00040

5-bromo-1,2-diphenyl-1H-imidazole 대신 7-bromo-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 4.08 g (10.5 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 7-(2-nitrophenyl)-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 4.11 g (9.56 mmol, yield: 91 %)을 얻었다.Except that 4.08 g (10.5 mmol) of 7-bromo-1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole was used instead of 5-bromo-1,2-diphenyl- , 4.11 g (9.56 mmol, yield) of 7- (2-nitrophenyl) -1,2-diphenyl-1,4-dihydroimidazo [4,5- b] indole were obtained in the same manner as in <Step 4> : 91%).

1H-NMR : δ 7.43 (m, 2H), 7.55 (m, 6H), 7.68 (m, 3H), 7.89 (m, 2H), 8.02 (m, 2H), 8.27 (d, 2H)
1 H-NMR: δ 7.43 ( m, 2H), 7.55 (m, 6H), 7.68 (m, 3H), 7.89 (m, 2H), 8.02 (m, 2H), 8.27 (d, 2H)

<단계 2> 4-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-7-(2-nitrophenyl)-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole의 합성Step 2: Synthesis of 4- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl-7- (2-nitrophenyl) -1,2-diphenyl-1,4-dihydroimidazo Synthesis of [4,5-b] indole

Figure 112012103902192-pat00041
Figure 112012103902192-pat00041

질소 기류 하에서 7-(2-nitrophenyl)-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 6.11 g (14.2 mmol), 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (11.0 g, 28.4 mmol), Cu powder (0.1 g, 1.42 mmol), K2CO3 (1.96 g, 14.2 mmol), Na2SO4 (2.02 g, 14.2 mmol), nitrobenzene (100 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. A solution of 6.11 g (14.2 mmol) of 7- (2-nitrophenyl) -1,2-diphenyl-1,4-dihydroimidazo [4,5- b] indole, 2- (3-bromophenyl) (1.0 g, 1.42 mmol), K 2 CO 3 (1.96 g, 14.2 mmol), Na 2 SO 4 (2.02 g, 14.2 mmol) nitrobenzene (100 ml) were mixed and stirred at 210 캜 for 12 hours.

반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피로 정제하여 4-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-7-(2-nitrophenyl)-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 7.23 g (9.80 mmol, yield: 69 %)을 얻었다. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removal of the solvent from the organic layer from which the water had been removed, the residue was purified by column chromatography to obtain 4- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl- -1,2-diphenyl-1,4-dihydroimidazo [4,5-b] indole were obtained in a yield of 69%.

1H-NMR : δ 7.43 (m, 5H), 7.56 (m, 11H), 7.68 (m, 2H), 7.89 (d, 1H), 8.01 (m, 4H), 8.27 (m, 8H)
1 H-NMR: δ 7.43 ( m, 5H), 7.56 (m, 11H), 7.68 (m, 2H), 7.89 (d, 1H), 8.01 (m, 4H), 8.27 (m, 8H)

<단계 3> IIC-7 과 IIC-8의 합성<Step 3> Synthesis of IIC-7 and IIC-8

Figure 112012103902192-pat00042
Figure 112012103902192-pat00042

5-(2-nitrophenyl)-1,2,4-triphenyl-1,4-dihydroimidazo[4,5-b]indole 대신 4-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-7-(2-nitrophenyl)-1,2-diphenyl-1,4-dihydroimidazo[4,5-b]indole 6.74 g (9.14 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 5>와 동일한 과정을 수행하여 IIC-7 2.39 g (3.38 mmol, yield: 37 %)와 IIC-8 2.58 g (3.66 mmol, yield: 40 %)을 얻었다.Instead of 4- (3- (4,6-diphenyl-1,3,5-triazin-1-yl) -1,2,4-triphenyl-1,4- dihydroimidazo [4,5- 2-yl) phenyl) -7- (2-nitrophenyl) -1,2-diphenyl-1,4-dihydroimidazo [4,5- b] indole. 2.39 g (3.38 mmol, yield: 37%) of IIC-7 and 2.58 g (3.66 mmol, yield: 40%) of IIC-8 were obtained in the same manner as in step 1 of Example 1.

IIC-7의 1H-NMR : δ 7.29 (t, 1H), 7.44 (m, 6H), 7.53 (m, 13H), 7.63 (d, 1H), 8.09 (m, 2H), 8.27 (m, 7H), 11.22 (s, 1H) 1 H-NMR of the IIC-7: δ 7.29 (t , 1H), 7.44 (m, 6H), 7.53 (m, 13H), 7.63 (d, 1H), 8.09 (m, 2H), 8.27 (m, 7H ), 11.22 (s, 1 H)

IIC-8의 1H-NMR : δ 7.29 (t, 1H), 7.45 (m, 5H), 7.52 (m, 12H), 7.63 (d, 1H), 7.99 (m, 3H), 8.12 (d, 1H), 8.28 (m, 7H), 11.22 (s, 1H)
Of IIC-8 1 H-NMR: δ 7.29 (t, 1H), 7.45 (m, 5H), 7.52 (m, 12H), 7.63 (d, 1H), 7.99 (m, 3H), 8.12 (d, 1H ), 8.28 (m, 7 H), 11.22 (s, 1 H)

[합성예 1] Inv-1의 합성[Synthesis Example 1] Synthesis of Inv-1

Figure 112012103902192-pat00043
Figure 112012103902192-pat00043

질소 기류 하에서 IIC-1 (3 g, 6.32 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (2.61 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.(3 g, 6.32 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (2.61 g, 7.59 mmol), Pd (OAc) 2 g, 5 mol%), NaO (t-bu) (1.52 g, 15.80 mmol), P (t-bu) 3 (0.13 g, 0.63 mmol) and a mixture of Toluene (100 ml) and for 12 hours at 110 ℃ Lt; / RTI &gt;

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 Inv-1 (3.36 g, 수율 68 %)을 얻었다. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain Inv-1 (3.36 g, yield 68%) .

GC-Mass (이론치: 781.30 g/mol, 측정치: 781 g/mol)
GC-Mass (theory: 781.30 g / mol, measured: 781 g / mol)

[합성예 2] Inv-2의 합성[Synthesis Example 2] Synthesis of Inv-2

Figure 112012103902192-pat00044
Figure 112012103902192-pat00044

질소 기류 하에서 IIC-1 (3 g, 6.32 mmol), 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (4.40 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)를 혼합하고 200℃에서 24시간 동안 교반하였다. (3 g, 6.32 mmol), 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine (4.40 g, 9.48 mmol), Cu powder 0.02 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml) were mixed and stirred at 200 ° C for 24 hours.

반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 1:1 (v/v))로 정제하여 Inv-2 (2.82 g, 수율 52 %)을 얻었다. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer from which water had been removed and then purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to obtain Inv-2 (2.82 g, yield 52%).

GC-Mass (이론치: 857.33 g/mol, 측정치: 857 g/mol)
GC-Mass (calculated: 857.33 g / mol, measured: 857 g / mol)

[합성예 3] Inv-3의 합성[Synthesis Example 3] Synthesis of Inv-3

Figure 112012103902192-pat00045
Figure 112012103902192-pat00045

IIC-1 (3 g, 6.32 mmol), 2-(4'-chlorobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.19 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 사용하여 상기 합성예 1과 동일한 방법으로 목적 화합물 Inv-3 (3.80 g, 수율 70 %)을 획득하였다. 3, 5-triazine (3.19 g, 7.59 mmol), Pd (OAc) 2 (3 g, 6.32 mmol) (0.07 g, 5 mol%) , NaO (t-bu) (1.52 g, 15.80 mmol), P (t-bu) 3 (0.13 g, 0.63 mmol) and Toluene (100 ml) using the above synthesis example 1 The target compound Inv-3 (3.80 g, yield 70%) was obtained.

GC-Mass (이론치: 857.33 g/mol, 측정치: 857 g/mol)
GC-Mass (calculated: 857.33 g / mol, measured: 857 g / mol)

[합성예 4] Inv-4의 합성[Synthesis Example 4] Synthesis of Inv-4

Figure 112012103902192-pat00046
Figure 112012103902192-pat00046

IIC-1 (3 g, 6.32 mmol), 2-(3-chlorophenyl)-4,6-diphenylpyridine (2.59 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물 Inv-4 (3.20 g, 수율 65 %)을 획득하였다. Pd (OAc) 2 (0.07 g, 5 mol%), NaO (t-Butylpyridine) (2.59 g, 7.59 mmol) bu) (1.52 g, 15.80 mmol ), P (t-bu) 3 (0.13 g, 0.63 mmol) and Toluene (100 ml), the above synthesis example 1, the same way the desired compound Inv-4 (3.20 g as and using , Yield 65%).

GC-Mass (이론치: 779.30 g/mol, 측정치: 779 g/mol)
GC-Mass (calculated: 779.30 g / mol, measured: 779 g / mol)

[합성예 5] Inv-5의 합성[Synthesis Example 5] Synthesis of Inv-5

Figure 112012103902192-pat00047
Figure 112012103902192-pat00047

IIC-1 (3 g, 6.32 mmol), 3-iodo-9-phenyl-9H-carbazole (3.50 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-5 (2.17 g, 수율 48 %)를 획득하였다.3-iodo-9-phenyl-9H-carbazole (3.50 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol) ), Na 2 SO 4 (0.90 g, using 6.32 mmol), nitrobenzene (100 ml ), to obtain the desired compound of Inv-5 (2.17 g, yield 48%) in the same manner as in synthesis example 2.

GC-Mass (이론치: 715.27 g/mol, 측정치: 715 g/mol)
GC-Mass (calculated: 715.27 g / mol, measured: 715 g / mol)

[합성예 6] Inv-6의 합성[Synthesis Example 6] Synthesis of Inv-6

Figure 112012103902192-pat00048
Figure 112012103902192-pat00048

IIC-1 (3 g, 6.32 mmol), iodobenzene (1.93 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-6 (1.88 g, 수율 54 %)를 획득하였다.(0.90 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 0.63 mmol), Iodobenzene (1.93 g, 6.32 mmol) and nitrobenzene (100 ml), Inv-6 (1.88 g, yield 54%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 550.22 g/mol, 측정치: 550 g/mol)
GC-Mass (calculated: 550.22 g / mol, measured: 550 g / mol)

[합성예 7] Inv-7의 합성[Synthesis Example 7] Synthesis of Inv-7

Figure 112012103902192-pat00049
Figure 112012103902192-pat00049

IIC-2 (3 g, 6.32 mmol), 6-bromo-2,3'-bipyridine (2.23 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-7 (1.95 g, 수율 49 %)를 획득하였다.Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), IIC-2 (3 g, 6.32 mmol), 6-bromo-2,3'-bipyridine (2.23 g, 9.48 mmol) , Na 2 SO 4 using a (0.90 g, 6.32 mmol), nitrobenzene (100 ml), to obtain the desired compound of Inv-7 (1.95 g, yield: 49%) in the same manner as in synthesis example 2.

GC-Mass (이론치: 628.24 g/mol, 측정치: 628 g/mol)
GC-Mass (calculated: 628.24 g / mol, measured: 628 g / mol)

[합성예 8] Inv-8의 합성[Synthesis Example 8] Synthesis of Inv-8

Figure 112012103902192-pat00050
Figure 112012103902192-pat00050

IIC-2 (3 g, 6.32 mmol), 2-bromoquinoline (1.97 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-8 (1.71 g, 수율 45 %)를 획득하였다.(0.07 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 0.63 mmol), IIC-2 (3 g, 6.32 mmol), 2-bromoquinoline g, 6.32 mmol) and nitrobenzene (100 ml), the target compound Inv-8 (1.71 g, yield 45%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 601.23 g/mol, 측정치: 601 g/mol)
GC-Mass (theory: 601.23 g / mol, measurement: 601 g / mol)

[합성예 9] Inv-9의 합성[Synthesis Example 9] Synthesis of Inv-9

Figure 112012103902192-pat00051
Figure 112012103902192-pat00051

IIC-2 (3 g, 6.32 mmol), 4-bromo-N,N-diphenylaniline (3.07 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-9 (2.09 g, 수율 46 %)를 획득하였다.Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), IIC-2 (3 g, 6.32 mmol), 4-bromo- N, N diphenylaniline (3.07 g, 9.48 mmol) Na 2 SO 4 using a (0.90 g, 6.32 mmol), nitrobenzene (100 ml), was obtained in Inv-9 (2.09 g, yield 46%) of the target compound in the same manner as in synthesis example 2.

GC-Mass (이론치: 717.29 g/mol, 측정치: 717 g/mol)
GC-Mass (calculated: 717.29 g / mol, measured: 717 g / mol)

[합성예 10] Inv-10의 합성[Synthesis Example 10] Synthesis of Inv-10

Figure 112012103902192-pat00052
Figure 112012103902192-pat00052

IIC-2 (3 g, 6.32 mmol), 2-bromo-4,6-diphenylpyridine (2.94 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-10 (2.14 g, 수율 48 %)를 획득하였다.Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), 2-bromo-4,6-diphenylpyridine (2.94 g, 9.48 mmol), IIC- Na 2 SO 4 using a (0.90 g, 6.32 mmol), nitrobenzene (100 ml), to obtain the desired compound of Inv-10 (2.14 g, yield 48%) in the same manner as in synthesis example 2.

GC-Mass (이론치: 703.27 g/mol, 측정치: 703 g/mol)
GC-Mass (calculated: 703.27 g / mol, measured: 703 g / mol)

[합성예 11] Inv-11의 합성[Synthesis Example 11] Synthesis of Inv-11

Figure 112012103902192-pat00053
Figure 112012103902192-pat00053

IIC-3 (3 g, 6.32 mmol), 2-chloro-4,6-diphenylpyrimidine (2.02 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물 Inv-11 (2.63 g, 수율 59 %)을 획득하였다. Pd (OAc) 2 (0.07 g, 5 mol%), NaO (t-Bu) (1.52 mmol) was added to a solution of 2-chloro-4,6-diphenylpyrimidine (2.02 g, 7.59 mmol) 11 (2.63 g, yield 59%) was obtained in the same manner as in Synthesis Example 1, except that P (t-bu) 3 (0.13 g, 0.63 mmol) and Toluene ).

GC-Mass (이론치: 704.27 g/mol, 측정치: 704 g/mol)
GC-Mass (calculated: 704.27 g / mol, measured: 704 g / mol)

[합성예 12] Inv-12의 합성[Synthesis Example 12] Synthesis of Inv-12

Figure 112012103902192-pat00054
Figure 112012103902192-pat00054

IIC-3 (3 g, 6.32 mmol), 3-(4-bromophenyl)pyridine (2.22 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2과 동일한 방법으로 목적 화합물인 Inv-12 (1.79 g, 수율 45 %)를 획득하였다.Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na (3-bromophenyl) pyridine (2.22 g, 9.48 mmol), IIC- Inv-12 (1.79 g, yield 45%) was obtained in the same manner as in Synthesis Example 2, using 2- SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml).

GC-Mass (이론치: 627.24 g/mol, 측정치: 627 g/mol)
GC-Mass (calculated: 627.24 g / mol, measured: 627 g / mol)

[합성예 13] Inv-13의 합성[Synthesis Example 13] Synthesis of Inv-13

Figure 112012103902192-pat00055
Figure 112012103902192-pat00055

질소 하에서 NaH 0.23 g (9.48 mmol)을 50 ml DMF 에 넣어 교반하였다. 여기에 DMF 50 ml에 녹인 IIC-3 3 g (6.32 mmol)을 천천히 첨가하고 1시간 가량 교반하였다. 이어서 DMF 100ml에 녹인 2-chloro-4,6-diphenyl-1,3,5-triazine 2.54 g (9.48 mmol)을 천천히 첨가하고 12시간 동안 교반하였다. 반응 종료 후 혼합물을 실리카 필터링하고 물과 메탄올로 씻은 후 용매를 제거하여 목적 화합물인 Inv-13 (3.26 g, 수율 73 %)을 얻었다.0.23 g (9.48 mmol) of NaH under nitrogen was added to 50 ml of DMF and stirred. 3 g (6.32 mmol) of IIC-3 dissolved in 50 ml of DMF was slowly added thereto, followed by stirring for about 1 hour. Then 2.54 g (9.48 mmol) of 2-chloro-4,6-diphenyl-1,3,5-triazine dissolved in 100 ml of DMF was added slowly and stirred for 12 hours. After completion of the reaction, the mixture was filtered through silica, washed with water and methanol, and then the solvent was removed to obtain the target compound Inv-13 (3.26 g, yield 73%).

GC-Mass (이론치: 705.26 g/mol, 측정치: 705 g/mol)
GC-Mass (calculated: 705.26 g / mol, measured: 705 g / mol)

[합성예 14] Inv-14의 합성[Synthesis Example 14] Synthesis of Inv-14

Figure 112012103902192-pat00056
Figure 112012103902192-pat00056

IIC-3 (3 g, 6.32 mmol), 3-bromobiphenyl (2.21 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여 합성예 2와 동일한 방법으로 목적 화합물인 Inv-14 (1.62 g, 수율 41 %)를 획득하였다.IIC-3 (3 g, 6.32 mmol), 3-bromobiphenyl (2.21 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml) were used to obtain Inv-14 (1.62 g, yield 41%) in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 626.25 g/mol, 측정치: 626 g/mol)
GC-Mass (calculated: 626.25 g / mol, measured: 626 g / mol)

[합성예 15] Inv-15의 합성[Synthesis Example 15] Synthesis of Inv-15

Figure 112012103902192-pat00057
Figure 112012103902192-pat00057

IIC-4 (3 g, 6.32 mmol), 5-bromo-2,2'-bipyridine (2.23 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-15 (1.71 g, 수율 43 %)를 획득하였다.(0.87 g, 6.32 mmol), Cu powder (0.04 g, 0.63 mmol), I 2 CO 3 (3 g, 6.32 mmol), 5-bromo-2,2'-bipyridine (2.23 g, 9.48 mmol) , Na 2 SO 4 using a (0.90 g, 6.32 mmol), nitrobenzene (100 ml), to obtain the desired compound of Inv-15 (1.71 g, 43% yield) in the same manner as in synthesis example 2.

GC-Mass (이론치: 628.24 g/mol, 측정치: 628 g/mol)
GC-Mass (calculated: 628.24 g / mol, measured: 628 g / mol)

[합성예 16] Inv-16의 합성[Synthesis Example 16] Synthesis of Inv-16

Figure 112012103902192-pat00058
Figure 112012103902192-pat00058

IIC-4 (3 g, 6.32 mmol), 4-chloro-2,6-diphenylpyrimidine (2.02 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물 Inv-16 (2.72 g, 수율 61 %)을 획득하였다. Pd (OAc) 2 (0.07 g, 5 mol%), NaO (t-Bu) (1.52 mmol), IIC-4 (3 g, 6.32 mmol), 4-chloro-2,6-diphenylpyrimidine g, 15.80 mmol), P ( t-bu) 3 (0.13 g, 0.63 mmol) and Toluene (100 ml) and the synthesis example 1, the same manner as the desired compound Inv-16 (2.72 g and using, yield: 61% ).

GC-Mass (이론치: 704.27 g/mol, 측정치: 704 g/mol)
GC-Mass (calculated: 704.27 g / mol, measured: 704 g / mol)

[합성예 17] Inv-17의 합성[Synthesis Example 17] Synthesis of Inv-17

Figure 112012103902192-pat00059
Figure 112012103902192-pat00059

IIC-4 (3 g, 6.32 mmol), 2-(3-bromophenyl)naphthalene (2.69 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-17 (1.71 g, 수율 40 %)를 획득하였다.Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 (3-bromophenyl) naphthalene (2.69 g, 9.48 mmol) Inv-17 (1.71 g, yield 40%) was obtained in the same manner as in Synthesis Example 2, using 2 SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml).

GC-Mass (이론치: 676.26 g/mol, 측정치: 676 g/mol)
GC-Mass (calculated: 676.26 g / mol, measured: 676 g / mol)

[합성예 18] Inv-18의 합성[Synthesis Example 18] Synthesis of Inv-18

Figure 112012103902192-pat00060
Figure 112012103902192-pat00060

IIC-4 (3 g, 6.32 mmol), 3-bromo-9-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-9H-carbazole (5.25 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-18 (2.16 g, 수율 36 %)를 획득하였다.3-bromo-9- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -9H-carbazole (5.25 g, 9.48 The same procedure as in Synthesis Example 2 (2) was carried out using Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 6.32 mmol) (2.16 g, yield 36%) of the desired compound, Inv-18, was obtained.

GC-Mass (이론치: 946.35 g/mol, 측정치: 946 g/mol)
GC-Mass (946.35 g / mol, measured: 946 g / mol)

[합성예 19] Inv-19의 합성[Synthesis Example 19] Synthesis of Inv-19

Figure 112012103902192-pat00061
Figure 112012103902192-pat00061

IIC-5 (3 g, 6.32 mmol), 3-bromopyridine (1.50 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-19 (1.81 g, 수율 52 %)를 획득하였다.IIC-5 (3 g, 6.32 mmol), 3-bromopyridine (1.50 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml), Inv-19 (1.81 g, yield 52%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 551.21 g/mol, 측정치: 551 g/mol)
GC-Mass (calculated: 551.21 g / mol, measured: 551 g / mol)

[합성예 20] Inv-20의 합성[Synthesis Example 20] Synthesis of Inv-20

Figure 112012103902192-pat00062
Figure 112012103902192-pat00062

IIC-5 (3 g, 6.32 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (2.61 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 1와 동일한 방법으로 목적 화합물 Inv-20 (3.31 g, 수율 67 %)을 획득하였다. IIC-5 (3 g, 6.32 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (2.61 g, 7.59 mmol), Pd (OAc) 2 (0.07 g, 5 use mol%), NaO (t- bu) (1.52 g, 15.80 mmol), P (t-bu) 3 (0.13 g, 0.63 mmol) and Toluene (100 ml), in the same manner as in synthesis example 1 The target compound Inv-20 (3.31 g, yield 67%) was obtained.

GC-Mass (이론치: 781.30 g/mol, 측정치: 781 g/mol)
GC-Mass (theory: 781.30 g / mol, measured: 781 g / mol)

[합성예 21] Inv-21의 합성[Synthesis Example 21] Synthesis of Inv-21

Figure 112012103902192-pat00063
Figure 112012103902192-pat00063

IIC-5 (3 g, 6.32 mmol), 2-bromo-6-phenylpyridine (2.22 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-21 (2.02 g, 수율 51 %)를 획득하였다., Cu 2 CO 3 (0.87 g, 6.32 mmol), Na 2 (0.02 g, 0.63 mmol), IIC-5 (3 g, 6.32 mmol), 2-bromo-6-phenylpyridine Inv-21 (2.02 g, yield 51%) was obtained in the same manner as in Synthesis Example 2, using SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml).

GC-Mass (이론치: 627.24 g/mol, 측정치: 627 g/mol)
GC-Mass (calculated: 627.24 g / mol, measured: 627 g / mol)

[합성예 22] Inv-22의 합성[Synthesis Example 22] Synthesis of Inv-22

Figure 112012103902192-pat00064
Figure 112012103902192-pat00064

IIC-6 (3 g, 6.32 mmol), 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (4.40 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-22 (2.50 g, 수율 46 %)를 획득하였다.IIC-6 (3 g, 6.32 mmol), 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine (4.40 g, 9.48 mmol) The target compound Inv-1 was obtained in the same manner as in Synthesis Example 2, using 0.63 mmol of K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 6.32 mmol) and nitrobenzene (100 ml) 22 (2.50 g, yield 46%).

GC-Mass (이론치: 857.33 g/mol, 측정치: 857 g/mol)
GC-Mass (calculated: 857.33 g / mol, measured: 857 g / mol)

[합성예 23] Inv-23의 합성[Synthesis Example 23] Synthesis of Inv-23

Figure 112012103902192-pat00065
Figure 112012103902192-pat00065

IIC-6 (3 g, 6.32 mmol), 2-bromonaphthalene (1.96 g, 9.48 mmol), Cu powder (0.04 g, 0.63 mmol), K2CO3 (0.87 g, 6.32 mmol), Na2SO4 (0.90 g, 6.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-23 (1.82 g, 수율 48 %)를 획득하였다.(0.04 g, 0.63 mmol), K 2 CO 3 (0.87 g, 6.32 mmol), Na 2 SO 4 (0.90 g, 0.63 mmol), IIC-6 (3 g, 6.32 mmol), 2-bromonaphthalene g, 6.32 mmol) and nitrobenzene (100 ml), Inv-23 (1.82 g, yield 48%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 600.23 g/mol, 측정치: 600 g/mol)
GC-Mass (theory: 600.23 g / mol, measurement: 600 g / mol)

[합성예 24] Inv-24의 합성[Synthesis Example 24] Synthesis of Inv-24

Figure 112012103902192-pat00066
Figure 112012103902192-pat00066

IIC-6 (3 g, 6.32 mmol), 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine (3.76 g, 7.59 mmol), Pd(OAc)2 (0.07 g, 5 mol%), NaO(t-bu) (1.52 g, 15.80 mmol), P(t-bu)3 (0.13 g, 0.63 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물 Inv-24 (3.84 g, 수율 65 %)을 획득하였다. (3 g, 6.32 mmol), 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -1,3,5-triazine (3.76 g, 7.59 mmol), Pd ) 2 (0.07 g, 5 mol%), NaO (t-bu) (1.52 g, 15.80 mmol), P (t-bu) 3 (0.13 g, 0.63 mmol) and Toluene The target compound Inv-24 (3.84 g, yield 65%) was obtained in the same manner as in Synthesis Example 1.

GC-Mass (이론치: 933.36 g/mol, 측정치: 933 g/mol)
GC-Mass (calculated: 933.36 g / mol, measured: 933 g / mol)

[합성예 25] Inv-25의 합성[Synthesis Example 25] Synthesis of Inv-25

Figure 112012103902192-pat00067
Figure 112012103902192-pat00067

IIC-7 (3 g, 4.25 mmol), iodobenzene (1.30 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K2CO3 (0.59 g, 4.25 mmol), Na2SO4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-25 (1.43 g, 수율 43 %)를 획득하였다.(0.30 g, 0.43 mmol), K 2 CO 3 (0.59 g, 4.25 mmol), Na 2 SO 4 (0.60 g, 0.43 mmol), Iodobenzene (1.30 g, 4.25 mmol) and nitrobenzene (100 ml), Inv-25 (1.43 g, yield 43%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 781.30 g/mol, 측정치: 781 g/mol)
GC-Mass (theory: 781.30 g / mol, measured: 781 g / mol)

[합성예 26] Inv-26의 합성[Synthesis Example 26] Synthesis of Inv-26

Figure 112012103902192-pat00068
Figure 112012103902192-pat00068

IIC-7 (3 g, 4.25 mmol), 2-bromo-4,6-diphenylpyridine (1.98 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K2CO3 (0.59 g, 4.25 mmol), Na2SO4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-26 (1.59 g, 수율 40 %)를 획득하였다.2-bromo-4,6-diphenylpyridine (1.98 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K 2 CO 3 (0.59 g, 4.25 mmol), IIC- Na 2 SO was obtained 4 (0.60 g, 4.25 mmol) , nitrobenzene (100 ml), the objective compound Inv-26 in the same manner as in synthesis example 2, using (1.59 g, yield 40%).

GC-Mass (이론치: 934.35 g/mol, 측정치: 934 g/mol)
GC-Mass (calculated: 934.35 g / mol, measured: 934 g / mol)

[합성예 27] Inv-27의 합성[Synthesis Example 27] Synthesis of Inv-27

Figure 112012103902192-pat00069
Figure 112012103902192-pat00069

IIC-7 (3 g, 4.25 mmol), 2-bromobiphenyl (1.49 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K2CO3 (0.59 g, 4.25 mmol), Na2SO4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-27 (1.39 g, 수율 38 %)를 획득하였다.IIC-7 (3 g, 4.25 mmol), 2-bromobiphenyl (1.49 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K 2 CO 3 (0.59 g, 4.25 mmol), Na 2 SO 4 (0.60 g, 4.25 mmol) and nitrobenzene (100 ml), Inv-27 (1.39 g, yield 38%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 857.33 g/mol, 측정치: 857 g/mol)
GC-Mass (calculated: 857.33 g / mol, measured: 857 g / mol)

[합성예 28] Inv-28의 합성[Synthesis Example 28] Synthesis of Inv-28

Figure 112012103902192-pat00070
Figure 112012103902192-pat00070

IIC-8 (3 g, 4.25 mmol), 1-bromo-3,5-diphenyl benzene (1.97 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K2CO3 (0.59 g, 4.25 mmol), Na2SO4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-28 (1.55 g, 수율 39 %)를 획득하였다.IIC-8 (3 g, 4.25 mmol), 1-bromo-3,5-diphenyl benzene (1.97 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K 2 CO 3 (0.59 g, 4.25 mmol) , Na 2 SO using 4 (0.60 g, 4.25 mmol) , nitrobenzene (100 ml), to obtain the desired compound of Inv-28 (1.55 g, yield 39%) in the same manner as in synthesis example 2.

GC-Mass (이론치: 933.36 g/mol, 측정치: 933 g/mol)
GC-Mass (calculated: 933.36 g / mol, measured: 933 g / mol)

[합성예 29] Inv-29의 합성[Synthesis Example 29] Synthesis of Inv-29

Figure 112012103902192-pat00071
Figure 112012103902192-pat00071

IIC-8 (3 g, 4.25 mmol), 4-(3-bromophenyl)dibenzo[b,d]thiophene (2.16 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K2CO3 (0.59 g, 4.25 mmol), Na2SO4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-28 (1.52 g, 수율 37 %)를 획득하였다.Dibenzo [b, d] thiophene (2.16 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K 2 CO 3 (0.59 g, , 4.25 mmol), using Na 2 SO 4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml), obtaining in Inv-28 (1.52 g, yield 37%) of the desired compound in the same manner as in synthesis example 2 Respectively.

GC-Mass (이론치: 963.31 g/mol, 측정치: 963 g/mol)
GC-Mass (calculated: 963.31 g / mol, measured: 963 g / mol)

[합성예 30] Inv-30의 합성[Synthesis Example 30] Synthesis of Inv-30

Figure 112012103902192-pat00072
Figure 112012103902192-pat00072

IIC-8 (3 g, 4.25 mmol), 4-bromobiphenyl (1.49 g, 6.38 mmol), Cu powder (0.03 g, 0.43 mmol), K2CO3 (0.59 g, 4.25 mmol), Na2SO4 (0.60 g, 4.25 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 2와 동일한 방법으로 목적 화합물인 Inv-30 (1.53 g, 수율 42 %)를 획득하였다.(0.09 g, 0.43 mmol), K 2 CO 3 (0.59 g, 4.25 mmol), Na 2 SO 4 (0.60 mmol), IIC-8 (3 g, 4.25 mmol), 4-bromobiphenyl g, 4.25 mmol) and nitrobenzene (100 ml), the target compound Inv-30 (1.53 g, yield 42%) was obtained in the same manner as in Synthesis Example 2. [

GC-Mass (이론치: 857.33 g/mol, 측정치: 857 g/mol)
GC-Mass (calculated: 857.33 g / mol, measured: 857 g / mol)

[합성예 31] Inv-31의 합성[Synthesis Example 31] Synthesis of Inv-31

Figure 112012103902192-pat00073
Figure 112012103902192-pat00073

질소 기류 하에서 IIC-1 (3 g, 6.32 mmol), 2-chloro-4-phenylquinazoline (1.83 g, 7.59 mmol), Pd(dba)3 (0.29 g, 5 mol%), K2CO3 (2.62 g, 18.97 mmol), BINAP (0.20 g, 5 mol%) 및 1,4-dioxane (50 ml)을 혼합하고 12시간 동안 환류교반하였다.Pd (dba) 3 (0.29 g, 5 mol%), K 2 CO 3 (2.62 g, 5 mmol), 2-chloro-4-phenylquinazoline (1.83 g, 7.59 mmol) , 18.97 mmol), BINAP (0.20 g, 5 mol%) and 1,4-dioxane (50 ml) were mixed and refluxed for 12 hours.

반응이 종결된 후 메틸렌클로라이드로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물이 Inv-31 (1.37 g, 수율 32 %)을 얻었다. After the reaction was completed, the reaction mixture was extracted with methylene chloride, then the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain Inv-31 (1.37 g, yield 32 %).

GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)
GC-Mass (calculated: 678.25 g / mol, measured: 678 g / mol)

[실시예 1 ~ 31] 유기 EL 소자의 제작[Examples 1 to 31] Fabrication of organic EL device

합성예 1-31에서 합성된 화합물 Inv-1 ~ Inv-31을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 EL 소자를 제작하였다.The compounds Inv-1 to Inv-31 synthesized in Synthesis Example 1-31 were subjected to high purity sublimation purification by a conventionally known method, and a green organic EL device was fabricated according to the following procedure.

먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium Tin Oxide) with a thickness of 1500 Å was washed with distilled water ultrasonic waves. After the distilled water was washed, the substrate was ultrasonically washed with a solvent such as isopropyl alcohol, acetone, or methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.

이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/Inv-1 ~ Inv-31의 각각의 화합물 + 10 % Ir(ppy)3 (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다. Each compound of m-MTDATA (60 nm) / TCTA (80 nm) / Inv-1 to Inv-31 + 10% Ir (ppy) 3 (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) in that order.

m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , CBP and BCP are as follows.

Figure 112012103902192-pat00074
Figure 112012103902192-pat00074

Figure 112012103902192-pat00075
Figure 112012103902192-pat00075

[비교예 1] 유기 EL 소자의 제작[Comparative Example 1] Fabrication of organic EL device

발광층 형성시 발광 호스트 물질로서 화합물 Inv-1 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 유기 EL 소자를 제작하였다.
An organic EL device was fabricated in the same manner as in Example 1, except that CBP was used instead of Compound Inv-1 as a luminescent host material in forming the light emitting layer.

[평가예][Evaluation example]

실시예 1-31 및 비교예 1에서 제작된 각각의 유기 EL 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, current efficiency and emission peak at a current density of 10 mA / cm 2 were measured for each of the organic EL devices manufactured in Example 1-31 and Comparative Example 1, and the results are shown in Table 1 below.

샘플Sample 호스트Host 구동 전압
(V)
Driving voltage
(V)
EL 피크
(nm)
EL peak
(nm)
전류효율
(cd/A)
Current efficiency
(cd / A)
실시예 1Example 1 Inv-1Inv-1 6.856.85 516516 38.338.3 실시예 2Example 2 Inv-2Inv-2 6.726.72 515515 39.439.4 실시예 3Example 3 Inv-3Inv-3 6.736.73 516516 39.039.0 실시예 4Example 4 Inv-4Inv-4 6.776.77 518518 39.339.3 실시예 5Example 5 Inv-5Inv-5 6.816.81 517517 40.140.1 실시예 6Example 6 Inv-6Inv-6 6.826.82 516516 41.041.0 실시예 7Example 7 Inv-7Inv-7 6.906.90 517517 39.939.9 실시예 8Example 8 Inv-8Inv-8 6.736.73 516516 39.139.1 실시예 9Example 9 Inv-9Inv-9 6.756.75 516516 39.539.5 실시예 10Example 10 Inv-10Inv-10 6.786.78 517517 39.239.2 실시예 11Example 11 Inv-11Inv-11 6.836.83 518518 38.638.6 실시예 12Example 12 Inv-12Inv-12 6.916.91 518518 39.739.7 실시예 13Example 13 Inv-13Inv-13 6.876.87 515515 40.640.6 실시예 14Example 14 Inv-14Inv-14 6.816.81 516516 39.939.9 실시예 15Example 15 Inv-15Inv-15 6.796.79 517517 39.739.7 실시예 16Example 16 Inv-16Inv-16 6.836.83 517517 38.638.6 실시예 17Example 17 Inv-17Inv-17 6.856.85 516516 39.539.5 실시예 18Example 18 Inv-18Inv-18 6.716.71 517517 40.540.5 실시예 19Example 19 Inv-19Inv-19 6.696.69 518518 39.939.9 실시예 20Example 20 Inv-20Inv-20 6.726.72 517517 38.538.5 실시예 21Example 21 Inv-21Inv-21 6.786.78 516516 39.639.6 실시예 22Example 22 Inv-22Inv-22 6.856.85 518518 39.339.3 실시예 23Example 23 Inv-23Inv-23 6.816.81 515515 38.938.9 실시예 24Example 24 Inv-24Inv-24 6.886.88 516516 39.039.0 실시예 25Example 25 Inv-25Inv-25 6.846.84 517517 40.340.3 실시예 26Example 26 Inv-26Inv-26 6.786.78 516516 39.739.7 실시예 27Example 27 Inv-27Inv-27 6.746.74 517517 39.539.5 실시예 28Example 28 Inv-28Inv-28 6.776.77 518518 38.838.8 실시예 29Example 29 Inv-29Inv-29 6.826.82 517517 39.039.0 실시예 30Example 30 Inv-30Inv-30 6.766.76 517517 39.139.1 실시예 31Example 31 Inv-31Inv-31 6.796.79 517517 41.341.3 비교예 1Comparative Example 1 CBPCBP 6.936.93 516516 38.238.2

상기 표 1에 나타낸 바와 같이, 본 발명에 따른 화합물(Inv-1 ~ Inv-31)을 발광층으로 사용하는 실시예 1-31의 녹색 유기 EL 소자는, 종래 CBP를 사용한 비교예 1의 녹색 유기 EL 소자와 비교해 볼 때 효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 알 수 있다.As shown in Table 1, the green organic EL device of Example 1-31 in which the compound (Inv-1 to Inv-31) according to the present invention was used as a light emitting layer was the green organic EL of Comparative Example 1 using CBP It can be seen that the device exhibits excellent performance in terms of efficiency and driving voltage as compared with the device.

Claims (8)

삭제delete 하기 화학식 3 내지 화학식 8 중 어느 하나로 표시되는 것을 특징으로 하는 화합물:
[화학식 3]
Figure 112015046648345-pat00078

[화학식 4]
Figure 112015046648345-pat00079

[화학식 5]
Figure 112015046648345-pat00080

[화학식 6]
Figure 112015046648345-pat00081

[화학식 7]
Figure 112015046648345-pat00082

[화학식 8]
Figure 112015046648345-pat00083

상기 화학식 3 내지 8에서,
X1 및 X2는 모두 N(Ar1)이며,
여기서 Ar1은 서로 동일하거나 또는 상이하며, 각각 독립적으로 C6~C40의 아릴기, 또는 핵원자수 5 내지 40의 헤테로아릴기이며,
R1 내지 R9 및 Ra는 서로 동일하거나 또는 상이하며, 각각 독립적으로 수소, 중수소, C1~C40의 알킬기, C6~C40의 아릴기, 및 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택되고,
n은 0 내지 4의 정수이고,
상기 R1 내지 R9, Ra 및 Ar1에서, C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기는, 각각 독립적으로 중수소, C1~C40의 알킬기, C6~C40의 아릴기, 및 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택되는 1종 이상으로 치환될 수 있다.
A compound represented by any one of the following formulas (3) to (8):
(3)
Figure 112015046648345-pat00078

[Chemical Formula 4]
Figure 112015046648345-pat00079

[Chemical Formula 5]
Figure 112015046648345-pat00080

[Chemical Formula 6]
Figure 112015046648345-pat00081

(7)
Figure 112015046648345-pat00082

[Chemical Formula 8]
Figure 112015046648345-pat00083

In the above Formulas 3 to 8,
X 1 and X 2 are both N (Ar 1 )
Wherein Ar 1 is the same or different and is each independently a C 6 to C 40 aryl group or a heteroaryl group having 5 to 40 nuclear atoms,
R 1 to R 9 and Ra are the same or different and each independently represents hydrogen, deuterium, a C 1 to C 40 alkyl group, a C 6 to C 40 aryl group, and a heteroaryl group having 5 to 40 nuclear atoms &Lt; / RTI &gt;
n is an integer from 0 to 4,
In the above R 1 to R 9, Ra and Ar 1, C 1 ~ C 40 alkyl group, C 6 ~ C 40 aryl group, nuclear atoms heteroaryl of 5 to 40 groups, each independently selected from deuterium, C 1 ~ C of A C 6 to C 40 aryl group, and a heteroaryl group having 5 to 40 nuclear atoms.
삭제delete 삭제delete 삭제delete 제2항에 있어서, 상기 Ar1은 하기 S1 내지 S204로 표시되는 치환체 군에서 선택되며, R1 내지 R9, 및 Ra는 각각 독립적으로 수소, 또는 하기 S1 내지 S204로 표시되는 치환체 군에서 선택되는 것을 특징으로 하는 화합물.
Figure 112015093889681-pat00084

Figure 112015093889681-pat00085

Figure 112015093889681-pat00086
The compound according to claim 2, wherein Ar 1 is selected from the substituent groups represented by the following S1 to S204, R 1 to R 9, and R a are each independently selected from the group consisting of hydrogen, &Lt; / RTI &gt;
Figure 112015093889681-pat00084

Figure 112015093889681-pat00085

Figure 112015093889681-pat00086
양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며,
상기 1층 이상의 유기물층 중 적어도 하나는 제2항 또는 제6항에 기재된 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자.
A cathode, and at least one organic layer interposed between the anode and the cathode,
Wherein at least one of the one or more organic layers includes the compound according to any one of claims 2 to 6.
제7항에 있어서, 상기 화합물을 포함하는 적어도 하나의 유기물층은 발광층인 것을 특징으로 하는 유기 전계 발광 소자.The organic electroluminescent device according to claim 7, wherein at least one organic compound layer containing the compound is a light emitting layer.
KR1020120145633A 2012-12-13 2012-12-13 Organic compounds and organic electro luminescence device comprising the same KR101612154B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020120145633A KR101612154B1 (en) 2012-12-13 2012-12-13 Organic compounds and organic electro luminescence device comprising the same
PCT/KR2013/011532 WO2014092483A1 (en) 2012-12-13 2013-12-12 Organic compound and organic electroluminescent element comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120145633A KR101612154B1 (en) 2012-12-13 2012-12-13 Organic compounds and organic electro luminescence device comprising the same

Publications (2)

Publication Number Publication Date
KR20140080682A KR20140080682A (en) 2014-07-01
KR101612154B1 true KR101612154B1 (en) 2016-04-14

Family

ID=50934678

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120145633A KR101612154B1 (en) 2012-12-13 2012-12-13 Organic compounds and organic electro luminescence device comprising the same

Country Status (2)

Country Link
KR (1) KR101612154B1 (en)
WO (1) WO2014092483A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108148073B (en) * 2016-12-06 2023-12-08 天光材料科技股份有限公司 Organic semiconductor compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012169821A1 (en) 2011-06-09 2012-12-13 Rohm And Haas Electronic Materials Korea Ltd. Novel compounds for organic electronic material and organic electroluminescent device using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2145936A3 (en) * 2008-07-14 2010-03-17 Gracel Display Inc. Fluorene and pyrene derivatives and organic electroluminescent device using the same
KR20100106014A (en) * 2009-03-23 2010-10-01 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20100118700A (en) * 2009-04-29 2010-11-08 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR101063940B1 (en) * 2009-08-26 2011-09-08 주식회사 두산 Novel organic compound and organic light emitting device using same
KR101274926B1 (en) * 2012-03-21 2013-06-17 주식회사 두산 Organic compounds and organic electroluminescent devices using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012169821A1 (en) 2011-06-09 2012-12-13 Rohm And Haas Electronic Materials Korea Ltd. Novel compounds for organic electronic material and organic electroluminescent device using the same

Also Published As

Publication number Publication date
KR20140080682A (en) 2014-07-01
WO2014092483A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
KR101560674B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101571591B1 (en) Organic compounds and organic electro luminescence device comprising the same
JP6244359B2 (en) Novel compound and organic electroluminescence device containing the same
KR101601356B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102508486B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20130073700A (en) Organic compound and organic electroluminescent devices using the same
KR101506793B1 (en) Organic electro luminescence device
KR101561338B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20180022189A (en) Organic compounds and organic electro luminescence device comprising the same
KR101571598B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150008678A (en) Organic compounds and organic electro luminescence device comprising the same
KR101577104B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101618411B1 (en) Organic light-emitting compound and organic electroluminescent device comprising the same
KR101576570B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150103968A (en) Organic compounds and organic electro luminescence device comprising the same
KR101641411B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101634852B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150053027A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20230047988A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101556819B1 (en) Organic compounds and organic electro luminescence device using the same
KR101548040B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101577099B1 (en) Organic compound and organic electroluminescent device comprising the same
KR101612154B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150086107A (en) Organic compounds and organic electro luminescence device comprising the same
KR20140033485A (en) Organic compound and organic electroluminescent devices using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190326

Year of fee payment: 4